View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Headline News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 19, 2024
6 min read
Save

'On the frontlines of public health': Physicians leverage trust against firearm violence

'On the frontlines of public health': Physicians leverage trust against firearm violence

Through counseling and advocacy, primary care providers can play an important role in preventing firearm injury, according to experts.

SPONSORED CONTENT
November 19, 2024
3 min read
Save

Chewing xylitol gum prenatally may reduce preterm birth, low birth weight deliveries

Chewing xylitol gum prenatally may reduce preterm birth, low birth weight deliveries

Chewing gum containing xylitol before conception and during pregnancy was associated with reduced preterm birth and low birth weight deliveries for women in Malawi, according to cluster-randomized trial data published in Med.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
November 19, 2024
10 min read
Save

Semaglutide could be ‘practice changing’ for adults with diabetes, CKD

Semaglutide could be ‘practice changing’ for adults with diabetes, CKD

The GLP-1 receptor agonist semaglutide may not only add another therapeutic option for chronic kidney disease, but it could also lead to changes in the way clinicians treat the condition.

SPONSORED CONTENT
November 19, 2024
1 min watch
Save

VIDEO: ONL1204 has different approach for treatment of geographic atrophy

VIDEO: ONL1204 has different approach for treatment of geographic atrophy

CHICAGO — In this video, Joan W. Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses study results presented at the AAO meeting on ONL1204 from ONL Therapeutics.

SPONSORED CONTENT
November 19, 2024
5 min read
Save

Physician uses life’s challenges to ‘change things for the better’

Physician uses life’s challenges to ‘change things for the better’

Monique A. Hartley-Brown, MD, MMSc, turns life challenges into the desire and initiative to “change things for the better.”

SPONSORED CONTENT
November 19, 2024
2 min read
Save

Obesity and MASLD increase risk for youth-onset type 2 diabetes

Obesity and MASLD increase risk for youth-onset type 2 diabetes

Children with obesity have increased risk for type 2 diabetes if they are diagnosed with metabolic dysfunction-associated steatotic liver disease, according to findings published in Diabetes Care.

SPONSORED CONTENT
November 19, 2024
3 min read
Save

Out-of-hospital cardiac arrest survival rates remain below pre-pandemic levels

Out-of-hospital cardiac arrest survival rates remain below pre-pandemic levels

CHICAGO — U.S. out-of-hospital cardiac arrest survival rates have improved since the first year of the COVID-19 pandemic, but have not returned to pre-pandemic levels, researchers reported.

SPONSORED CONTENT
November 19, 2024
3 min read
Save

Healthy diet ‘a concrete step’ to reduce risk for prostate cancer progression

Healthy diet ‘a concrete step’ to reduce risk for prostate cancer progression

Greater adherence to American dietary guideline recommendations appeared linked with reduced likelihood of prostate cancer progression among men undergoing active surveillance, study results showed.

SPONSORED CONTENT
November 19, 2024
2 min read
Save

Practice-level policies ‘likely key drivers’ of infliximab biosimilar uptake

Practice-level policies ‘likely key drivers’ of infliximab biosimilar uptake

WASHINGTON — Biosimilar infliximab use is significantly more common among new users vs. those who started with the originator, and particularly less likely among Medicare beneficiaries, according to data presented at ACR Convergence 2024.

SPONSORED CONTENT
November 19, 2024
1 min read
Save

Adverum reports positive 52-week, 4-year data for wet AMD gene therapy

Adverum reports positive 52-week, 4-year data for wet AMD gene therapy

Adverum Biotechnologies reported positive 52-week data from the phase 2 LUNA trial as well as long-term follow-up results from the OPTIC trial of Ixo-vec in patients with wet age-related macular degeneration.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails